Freestone Capital Holdings’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$224K Buy
2024
Q2
Sell
2024
Q1
$247K Hold
2023
Q4
$227K Buy
2023
Q3
Sell
2023
Q2
$204K Buy
2022
Q1
Sell
2021
Q4
$225K Buy
2021
Q3
$314K Sell
2021
Q2
$462K Buy
2021
Q1
Sell
2020
Q4
$67.2K Buy
2020
Q3
$9.12K Buy